Work

Figure S3 from In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models

Year: 2026

Type: other

Abstract: TRT+DCP+ISV activates a potent T cell immune memory response.

DOI: 10.1158/2326-6066.33414263

Authors: Trishna Debnath, Won Jong Jin, Ravi B. Patel, Peter M. Carlson, Md Mahfuzur Rahman, Tracy J. Berg, Caroline P. Kerr, Rene Welch Schwartz, Yujuan Wang, Meredith Hyun, Irene M. Ong, Jamey P. Weichert, Reinier Hernandez, Paul M. Sondel, Zachary S. Morris

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7204993855

Cites:

Cited by:

Related to: